These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16783109)

  • 41. Clostridium difficile 027 emerging outbreak in Marseille, France.
    Lagier JC; Dubourg G; Cassir N; Fournier PE; Colson P; Richet H; Brouqui P; Raoult D
    Infect Control Hosp Epidemiol; 2013 Dec; 34(12):1339-41. PubMed ID: 24225631
    [No Abstract]   [Full Text] [Related]  

  • 42. An outbreak of toxin A negative, toxin B positive Clostridium difficile-associated diarrhea in a Canadian tertiary-care hospital.
    al-Barrak A; Embil J; Dyck B; Olekson K; Nicoll D; Alfa M; Kabani A
    Can Commun Dis Rep; 1999 Apr; 25(7):65-9. PubMed ID: 10344088
    [No Abstract]   [Full Text] [Related]  

  • 43. Clostridium difficile--Second International Symposium (ICDS).
    Tillotson G
    IDrugs; 2007 Aug; 10(8):538-42. PubMed ID: 17665327
    [No Abstract]   [Full Text] [Related]  

  • 44. Clostridium difficile infection.
    Stanley JD; Bartlett JG; Dart BW; Ashcraft JH
    Curr Probl Surg; 2013 Jul; 50(7):302-37. PubMed ID: 23764494
    [No Abstract]   [Full Text] [Related]  

  • 45. Surgical-site infection with toxin A-nonproducing and toxin B-producing Clostridium difficile.
    Kikkawa H; Miyamoto K; Takiguchi N; Kondo T; Hitomi S
    J Infect Chemother; 2008 Feb; 14(1):59-61. PubMed ID: 18297452
    [TBL] [Abstract][Full Text] [Related]  

  • 46. What has made the difference?
    Elston T
    J Hosp Infect; 2010 Jun; 75(2):136; author reply 136-7. PubMed ID: 20381899
    [No Abstract]   [Full Text] [Related]  

  • 47. [Clostridium-difficile-associated infections].
    Eckert C; Barbut F
    Med Sci (Paris); 2010 Feb; 26(2):153-8. PubMed ID: 20188046
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents.
    Riggs MM; Sethi AK; Zabarsky TF; Eckstein EC; Jump RL; Donskey CJ
    Clin Infect Dis; 2007 Oct; 45(8):992-8. PubMed ID: 17879913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decrease of hypervirulent Clostridium difficile PCR ribotype 027 in the Netherlands.
    Hensgens MP; Goorhuis A; Notermans DW; van Benthem BH; Kuijper EJ
    Euro Surveill; 2009 Nov; 14(45):. PubMed ID: 19941791
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clostridium difficile infection in the Republic of Ireland: results of a 1-month national surveillance and ribotyping project, March 2009.
    Burns K; Skally M; Solomon K; Scott L; McDermott S; O'Flanagan D; Fanning S; Kyne L; Fenelon L; Fitzpatrick F
    Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1085-7. PubMed ID: 20731596
    [No Abstract]   [Full Text] [Related]  

  • 51. Nosocomial outbreak of Clostridium difficile-associated disease in a pediatric intensive care unit in Madrid.
    Bustinza A; Solana MJ; Padilla B; López-Herce J; Santiago MJ; Marin M
    Infect Control Hosp Epidemiol; 2009 Feb; 30(2):199-201. PubMed ID: 19090768
    [No Abstract]   [Full Text] [Related]  

  • 52. Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001.
    Archibald LK; Banerjee SN; Jarvis WR
    J Infect Dis; 2004 May; 189(9):1585-9. PubMed ID: 15116293
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clostridium difficile: responding to a new threat from an old enemy.
    McDonald LC
    Infect Control Hosp Epidemiol; 2005 Aug; 26(8):672-5. PubMed ID: 16156321
    [No Abstract]   [Full Text] [Related]  

  • 54. Introduction to the special issue on Clostridium difficile.
    Johnson S; Gerding DN
    Anaerobe; 2009 Dec; 15(6):225-6. PubMed ID: 19944988
    [No Abstract]   [Full Text] [Related]  

  • 55. Distribution of Clostridium difficile PCR ribotype 027 in British hospitals.
    Brazier JS; Patel B; Pearson A
    Euro Surveill; 2007 Apr; 12(4):E070426.2. PubMed ID: 17868609
    [No Abstract]   [Full Text] [Related]  

  • 56. Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands.
    Goorhuis A; Van der Kooi T; Vaessen N; Dekker FW; Van den Berg R; Harmanus C; van den Hof S; Notermans DW; Kuijper EJ
    Clin Infect Dis; 2007 Sep; 45(6):695-703. PubMed ID: 17712752
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Update on the changing epidemiology of Clostridium difficile-associated disease.
    McFarland LV
    Nat Clin Pract Gastroenterol Hepatol; 2008 Jan; 5(1):40-8. PubMed ID: 18174906
    [TBL] [Abstract][Full Text] [Related]  

  • 58. First cluster of C. difficile toxinotype III, PCR-ribotype 027 associated disease in France: preliminary report.
    Tachon M; Cattoen C; Blanckaert K; Poujol I; Carbonne A; Barbut F; Petit JC; Coignard B
    Euro Surveill; 2006 May; 11(5):E060504.1. PubMed ID: 16816455
    [No Abstract]   [Full Text] [Related]  

  • 59. [Changing epidemiology of infections in the Netherlands in 2008/'09].
    Hensgens MP; Goorhuis A; Notermans DW; van Benthem BH; Kuijper EJ
    Ned Tijdschr Geneeskd; 2010; 154():A1317. PubMed ID: 20619033
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Update on Clostridium difficile infections].
    Blanckaert K; Coignard B; Grandbastien B; Astagneau P; Barbut F
    Rev Med Interne; 2008 Mar; 29(3):209-14. PubMed ID: 18023937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.